Search - tctmd.com

Displaying 581 - 600 of 722

Sort: Relevancy | Date

Presentation TCT 2013

How We Should Define "Responsiveness" to Renal Denervation Therapies

Presenter: Krishna Rocha-Singh

October 27, 2013

Presentation TCT 2013

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Presenter: Andrew Farb

October 27, 2013

Presentation TCT 2013

Ethanol Injection for Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 27, 2013

Presentation TCT 2013

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Presenter: Vivek Reddy

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Presenter: Marc Sapoval

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Presenter: Jan Pietzsch

October 27, 2013

Presentation TCT 2013

Chemical Ablation for Renal Denervation (Northwind Technologies)

Presenter: Mark Wholey

October 27, 2013

Presentation TCT 2013

Case Presentation: Hypertension Therapies and Renal Denervation

Presenter: Ajay Kirtane

October 27, 2013

Presentation TCT 2013

Beta-Radiation for Renal Denervation (Best Medical)

Presenter: Ron Waksman

October 27, 2013

News Industry News

Creganna-Tactx Medical to Showcase Expertise in Emerging Medical Therapies at TCT 2013

October 22, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal

September 13, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

Presentation

Impaired Cardiac Baroreflex Sensitivity (BRS) Predicts Response to Renal Denervation in Patients with Resistant Hypertension

Presenter: C. S. Zuern

August 22, 2013

Presentation SOLACI 2013

Understanding the Basics Behind Renal Denervation

Presenter: Ramiro Sanchez

July 25, 2013

Presentation SOLACI 2013

Renal Denervation: New Data and Future Directions

Presenter: Felix Mahfoud

July 25, 2013

Advertisement

How We Should Define "Responsiveness" to Renal Denervation Therapies

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Ethanol Injection for Renal Denervation (Ablative Solutions)

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Chemical Ablation for Renal Denervation (Northwind Technologies)

Case Presentation: Hypertension Therapies and Renal Denervation

Beta-Radiation for Renal Denervation (Best Medical)

Creganna-Tactx Medical to Showcase Expertise in Emerging Medical Therapies at TCT 2013

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Impaired Cardiac Baroreflex Sensitivity (BRS) Predicts Response to Renal Denervation in Patients with Resistant Hypertension

Understanding the Basics Behind Renal Denervation

Renal Denervation: New Data and Future Directions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content